(RTTNews) - Insurance software company Majesco (MJCO) announced Monday that it has signed a definitive agreement to be taken private by private equity firm Thoma Bravo, L.P. in a transaction valuing the company at $594 million.
In this episode of MarketFoolery, host Chris Hill chats with analyst Bill Mann about the latest financial reports and news from Wall Street. They talk about the recent Twitter (NYSE: TWTR) hack. A medical devices and consumer goods giant announced lower earnings, but bumped up i
Walmart, the world's biggest retailer, has restarted talks with potential buyers of a stake in its British supermarket arm Asda, a Walmart spokesman said on Monday.
IndiGo, India's biggest airline, said it will cut 10% of its workforce as it grapples with declining revenues due to the fallout from the COVID-19 pandemic. Impacted employees will get a severance pay and will be paid for the notice period as well.
(RTTNews) - Sorrento Therapeutics Inc. (SRNE) said that it received clearance from the FDA to initiate a Phase 2 trial of Abivertinib in patients with COVID-19 who have moderate to severe pulmonary symptoms.
Pershing Square Tontine Holdings, a blank check company formed by Bill Ackman of Pershing Square targeting "Mature Unicorns," is expected to price this week.
For access to exact trade dates, screening capabilities, and other features, sign up for a free trial of IPO Pro.
The New
Health care firms were advancing in early trading Monday with the Health Care SPDR (XLV) up 0.37% and the iShares NASDAQ Biotechnology Index (IBB) 0.36% higher recently.
ACell, which makes surgical soft tissue implants for wounds and hernia repair, postponed its IPO on Monday. It had filed to raise $75 million by offering 5 million shares at a price range of $14 to $16.
The Columbia, MD-based company was founded in 1999 and booked $100 million in
(RTTNews) - Flowers Foods, Inc. (FLO) said it expects second quarter GAAP earnings per share to be in the range of $0.25 to $0.28. Earnings per share, adjusted for items, are anticipated to be in the range of $0.30 to $0.33. On average, six analysts polled by Thomson Reuters exp
SPECIAL ALERT: We’ve just released our new 5 Stocks Set to Double Special Report which includes five stocks our team believes have the potential to grow +100% in the next 12 months. This latest report features favorite stocks from Kevin Cook, David Borun, Ben Rains, Dan Labo
Nurix Therapeutics, a preclinical biotech developing small molecule therapies for cancer, announced terms for its IPO on Monday.
The San Francisco, CA-based company plans to raise $150 million by offering 8.8 million shares at a price range of $16 to $18. At the midpoint of the p
In today's world of no-fee discount brokers, real-time alerts, and the 24/7 news cycle, investors can often get lost, confused, and emotional. At its worst, today's financial media encourages investors to take excess action, which is actually one of the worst things one can do i
(RTTNews) - While reporting financial results for the second quarter on Monday, workforce solutions provider ManpowerGroup, Inc. (MAN) said it expects earnings for the third quarter to be in the range of $0.59 to $0.67 per share, which includes an estimated unfavorable currency
Japanese drugmaker Shionogi & Co aims to boost production capacity for its potential coronavirus vaccine to produce enough for 30 million people annually by the end of 2021, a company official told Reuters on Monday.
Property data and analytics firm CoreLogic Inc said on Monday it would not open its books to investment firms Senator Investment Group LP and Cannae Holdings Inc unless they raise their $7 billion offer to buy the company.